HK1246679A1 - 絲蟲病的治療 - Google Patents

絲蟲病的治療

Info

Publication number
HK1246679A1
HK1246679A1 HK18106302.0A HK18106302A HK1246679A1 HK 1246679 A1 HK1246679 A1 HK 1246679A1 HK 18106302 A HK18106302 A HK 18106302A HK 1246679 A1 HK1246679 A1 HK 1246679A1
Authority
HK
Hong Kong
Prior art keywords
treatment
filarial
diseases
filarial diseases
Prior art date
Application number
HK18106302.0A
Other languages
English (en)
Inventor
Geldern Thomas W Von
Dale J Kempf
Kennan C Marsh
Mark John Taylor
Stephen Andrew Ward
Louise Ford
Joseph Turner
Original Assignee
Abbvie Inc
Liverpool School Tropical Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc, Liverpool School Tropical Medicine filed Critical Abbvie Inc
Publication of HK1246679A1 publication Critical patent/HK1246679A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
HK18106302.0A 2015-01-09 2018-05-15 絲蟲病的治療 HK1246679A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562101484P 2015-01-09 2015-01-09
PCT/US2016/012687 WO2016112317A1 (en) 2015-01-09 2016-01-08 Treatment of filarial diseases

Publications (1)

Publication Number Publication Date
HK1246679A1 true HK1246679A1 (zh) 2018-09-14

Family

ID=56356487

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18106302.0A HK1246679A1 (zh) 2015-01-09 2018-05-15 絲蟲病的治療

Country Status (5)

Country Link
US (1) US10238677B2 (zh)
EP (1) EP3242662A4 (zh)
CA (1) CA2973383A1 (zh)
HK (1) HK1246679A1 (zh)
WO (1) WO2016112317A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3116888A1 (en) 2014-03-11 2017-01-18 AbbVie Inc. 4"-0-substituted tylosin a derivatives
GB202100635D0 (en) * 2021-01-18 2021-03-03 Liverpool School Tropical Medicine Compounds and methods for treating or preventing dirofilaria infection in a mammal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813595A (ja) 1981-06-11 1983-01-26 Toyo Jozo Co Ltd ４″−ｏ−置換カルバモイル−タイロシン
US4436733A (en) 1982-03-03 1984-03-13 Eli Lilly And Company 4"- And 3-ester derivatives of DMT and DMOT
WO2009064953A1 (en) 2007-11-15 2009-05-22 Enanta Pharmaceuticals, Inc. Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
UA108641C2 (uk) * 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
WO2013057624A1 (en) 2011-10-19 2013-04-25 Ah Usa 42 Llc Use of aminoacetonitrile derivatives against endoparasites
US20160200757A1 (en) 2014-03-11 2016-07-14 Abbvie Inc. Tylosin a analogs and derivatives
EP3116888A1 (en) 2014-03-11 2017-01-18 AbbVie Inc. 4"-0-substituted tylosin a derivatives

Also Published As

Publication number Publication date
EP3242662A4 (en) 2018-08-01
EP3242662A1 (en) 2017-11-15
CA2973383A1 (en) 2016-07-14
US20170368088A1 (en) 2017-12-28
WO2016112317A1 (en) 2016-07-14
US10238677B2 (en) 2019-03-26

Similar Documents

Publication Publication Date Title
GB201701673D0 (en) Methods of well treatment
FI3851537T3 (fi) Hyperbilirubinemian hoito
SG11201609652RA (en) Treatment of polybacterials infections
HK1258994A1 (zh) 用於疾病治療的方法
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
HK1231380A1 (zh) 嚴重高甘油三酯血症的治療
HK1247818A1 (zh) 治療疾病的方法
GB201410116D0 (en) Method of treatment
GB201516905D0 (en) Treatment of Neurodegenerative diseases
GB201416832D0 (en) Methods of treatment
GB201412578D0 (en) Treatment of neurological diseases
IL253028A0 (en) treatment method
HK1246679A1 (zh) 絲蟲病的治療
HK1243937A1 (zh) 治療疾病的方法
LT3302499T (lt) Mitochondrinių ligų gydymas
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
AU2015905220A0 (en) Methods of treatment
GB201514909D0 (en) Treatment of autoimmune diseases
GB201517565D0 (en) Treatment of genetic diseases
GB201512635D0 (en) Uses of therapeutic compounds
GB201511017D0 (en) Method of treatment
GB201522257D0 (en) Treatment of autism
GB201504413D0 (en) Treatment of disease
PT3851537T (pt) Tratamento da hiperbilirrubinemia